Results 191 to 200 of about 1,150,712 (337)

Membrane Fusion‐Inspired Nanomaterials: Emerging Strategies for Infectious Disease and Cancer Diagnostics

Advanced Healthcare Materials, EarlyView.
Membrane fusion‐inspired nanomaterials offer transformative potential in diagnostics by mimicking natural fusion processes to achieve highly sensitive and specific detection of disease biomarkers. This review highlights recent advancements in nanomaterial functionalization strategies, signal amplification systems, and stimuli‐responsive fusion designs,
Sojeong Lee, Khulan Nyamzaya, Jueun Han, Yejin Song, Jihee Lee, Jung Hyun Jo, Seungmin Bang, Eun‐Kyung Lim, Seungjoo Haam, Eunjung Kim   +9 more
wiley   +1 more source

Genetic alterations of prostate cancer: in localized and metastatic prostate cancer. [PDF]

BMC Urol
Yoon CE, Kang S, Rhew SA, Kwon HJ, Shin D, Moon HW, Kim MY, Lee JY.   +7 more
europepmc   +1 more source

CYTOLOGIC STUDY OF THE PROSTATIC SMEAR, ESPECIALLY IN PROSTATIC CANCER

, 1960
Haruo Hisazumi
openalex   +2 more sources

Selecting initial therapy for prostate cancer. Radiation therapy perspective [PDF]

, 1987
Malcolm A. Bagshaw, Gordon R. Ray, Richard S. Cox   +2 more
openalex   +1 more source

Nanobody‐Decorated Lipid Nanoparticles for Enhanced mRNA Delivery to Tumors In Vivo

Advanced Healthcare Materials, EarlyView.
This study presents a targeted mRNA‐LNP platform engineered with anti‐PSMA nanobodies for prostate cancer therapy. Using different in vivo models, the authors demonstrate selective uptake and mRNA delivery in PSMA+ cancer cells. However, while targeting is enhanced, mRNA delivery efficacy is limited by tissue penetration, tumor necrosis, and immune ...
Pol Escudé Martinez de Castilla, Vincenzo Verdi, Willemijn de Voogt, Mariona Estapé Sentí, Arnold C. Koekman, Julian Rietveld, Sven van Kempen, Qiangbing Yang, Juliette van Merris, Guido Jenster, Martin E. van Royen, Marcel H. Fens, Sander A. A. Kooijmans, Wytske M. van Weerden, Guillaume van Niel, Pieter Vader, Raymond M. Schiffelers   +16 more
wiley   +1 more source

ESTIMATION OF URINARY 17-HYDROXYCORTICOIDS IN PROSTATE CANCER

, 1960
Yoshio Aso
openalex   +2 more sources

Kinetic analysis of prostatic volume in treating prostatic cancer and its predictability for prognosis [PDF]

, 1988
Hiroshi Ohe, Hiroki Watanabe
openalex   +1 more source

Interstitial N‐Strengthened Copper‐Based Bioactive Conductive Dressings Combined with Electromagnetic Fields for Enhanced Wound Healing

Advanced Healthcare Materials, EarlyView.
This study developed a nitrogen‐strengthened copper‐iron‐zinc (N‐CuFeZn) alloy bioactive dressing integrated with electromagnetic stimulation. The coaxial dressing, made from 0.04 mm filaments with 1120 MPa tensile strength, showed that electromagnetic activation enhanced therapeutic outcomes by increasing VEGF expression, promoting angiogenesis (2.1 ...
Xiaohui Qiu, Xianrui Wu, Shaohua Wang, Jie Gu, Senhao Ying, Jiaohao Mo, Chen Jing, Huiliang Cao, Zhongchang Wang, Jianda Zhou   +9 more
wiley   +1 more source

The natural history of prostate cancer. [PDF]

Can Urol Assoc J
O'Connell C, Bernardino RM, Fleshner NE.
europepmc   +1 more source

THE MECHANISM OF THE ANTI-ANDROGENIC THERAPY FOR PROSTATIC CANCER

, 1961
Syunji Matsumoto
openalex   +2 more sources